SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-16-019869
Filing Date
2016-11-14
Accepted
2016-11-14 17:20:37
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1602699_10q.htm 10-Q 579913
2 EXHIBIT 31.1 t1602699_ex31-1.htm EX-31.1 10076
3 EXHIBIT 31.2 t1602699_ex31-2.htm EX-31.2 9887
4 EXHIBIT 32.1 t1602699_ex32-1.htm EX-32.1 3260
5 EXHIBIT 32.2 t1602699_ex32-2.htm EX-32.2 3491
  Complete submission text file 0001571049-16-019869.txt   2924675

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cycc-20160930.xml EX-101.INS 433304
7 XBRL SCHEMA FILE cycc-20160930.xsd EX-101.SCH 34516
8 XBRL CALCULATION FILE cycc-20160930_cal.xml EX-101.CAL 31083
9 XBRL DEFINITION FILE cycc-20160930_def.xml EX-101.DEF 119106
10 XBRL LABEL FILE cycc-20160930_lab.xml EX-101.LAB 305395
11 XBRL PRESENTATION FILE cycc-20160930_pre.xml EX-101.PRE 216607
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 161995946
SIC: 2834 Pharmaceutical Preparations